TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6).

Paul Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.